D3 FastPoint is a Revolutionary Technology that allows for the detection of up to 8 viruses with DFA accuracy in under 25 minutes from specimen receipt to virus detection.
Thyretain is the only commercially available in vitro diagnostic test that specifically detects TSI* and may aid your differential diagnosis of Graves’ Disease.
Quidel offers comprehensive
Reimbursement Support from start to finish.
ProductsDiagnostic Hybrids innovates, develops, manufactures and markets cellular and molecular diagnostic kits for various applications in detecting a wide range of respiratory diseases, herpes infections, thyroid function, and other high value markers of disease. Our products provide an accurate, rapid and cost-effective diagnosis, and our products are changing the way people use technologies to more effectively diagnose and treat respiratory and other diseases.
Diagnostic Hybrids' product catalog offers innovative solutions for all of your laboratory's testing needs. Please use the links below or contact us for additional information.
Diagnostic Hybrids is going GREEN!
Effective March 19, 2012, printed copies of Product Inserts (instructions for use) and Material Safety Data Sheets will no longer be included in your shipments. These documents, as well as Product Status Reports (Passage Sheets) and Lot Specification Reports, will be readily available for automatic download on the Diagnostic Hybrids' website at: dhiusa.com under the ‘RESOURCES’ tab. Paper copies are available by contacting Technical Support at technicalsupport@quidel.com or calling (800) 874-1517, option 2 and then option 3.
NewsApril 20, 2012
Quidel Receives CLIA Waiver for Its Sofia(TM) Analyzer and Sofia Influenza A+B Fluorescent Immunoassay (FIA) Read moreApril 13, 2012
Quidel to Hold First Quarter 2012 Financial Results Conference Call on April 25, 2012 Read moreApril 02, 2012
Quidel Receives CE Mark for Its Direct Specimen Rapid PCR Test for Toxigenic Clostridium Difficile Read more